Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001213773 | SCV001385423 | uncertain significance | Exostoses, multiple, type 2 | 2024-01-23 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 307 of the EXT2 protein (p.Asp307Asn). This variant is present in population databases (rs200631641, gnomAD 0.04%). This missense change has been observed in individual(s) with multiple osteochondromas (PMID: 19810120). ClinVar contains an entry for this variant (Variation ID: 943564). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt EXT2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |